Henry Gabbay - BlackRock Science Independent Trustee
| BST Etf | USD 34.10 0.00 0.00% |
Mr. Henry Gabbay is Trustee of BlackRock Science Technology Trust. The Board benefits from Mr. Gabbays many years of experience in administration finance and financial services operations. Mr. Gabbays experience as a Managing Director of BlackRock Chief Administrative Officer of BlackRock Advisors LLC and President of BlackRock Funds provides the Board with insight into investment company operational financial and investment matters. Mr. Gabbays former positions as Chief Administrative Officer of BlackRock Advisors LLC and as Treasurer of certain closedend funds in the ClosedEnd Complex provide the Board with direct knowledge of the operations of the Trust and its investment advisor. Mr. Gabbays longstanding service on the boards of the ClosedEnd Complex also provides him with a specific understanding of the Trust its operations and the business and regulatory issues facing the Trust
| Age | 72 |
| Tenure | 6 years |
| Phone | 212 810 5300 |
| Web | https://www.blackrock.com/investing/products/270141/blackrock-science-and-technology-trust-fund |
Henry Gabbay Latest Insider Activity
Tracking and analyzing the buying and selling activities of Henry Gabbay against BlackRock Science etf is an integral part of due diligence when investing in BlackRock Science. Henry Gabbay insider activity provides valuable insight into whether BlackRock Science is net buyers or sellers over its current business cycle. Note, BlackRock Science insiders must abide by specific rules, including filing SEC forms every time they buy or sell BlackRock Science'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Henry Gabbay over three months ago Insider Trading | ||
Henry Gabbay over a year ago Acquisition by Henry Gabbay of tradable shares of BlackRock Core at 11.6062 subject to Rule 16b-3 | ||
Henry Gabbay over a year ago Purchase by Henry Gabbay of 100 shares of BlackRock Investment |
Similar Fund Executives
| Showing other executives | One Year Return | ||
| William Reardon | Tekla Healthcare Investors | 74 | |
| John Maney | Pimco Corporate Income | 62 | |
| Lisa Phelan | Cohen Steers Total | 51 | |
| Christopher MBA | Tekla Healthcare Investors | N/A | |
| Lucinda Stebbins | Tekla Healthcare Investors | 73 | |
| Joseph Beranek | Columbia Seligman Premium | 55 | |
| Xiang Liu | BlackRock Health Sciences | N/A | |
| Alan Rappaport | Pimco Corporate Income | 68 | |
| Kyle CFA | BlackRock Utility Infrastructur | N/A | |
| Cynthia Frost | Eaton Vance Enhanced | 60 | |
| Erik Brown | Pimco Corporate Income | 54 | |
| Christopher Accettella | BlackRock Health Sciences | N/A | |
| Helen Peters | Eaton Vance Enhanced | 73 | |
| Mary Anstine | Reaves Utility If | 79 | |
| Dana Devivo | Cohen Steers Total | 39 | |
| Janey Ahn | BlackRock Health Sciences | 46 | |
| Karen Gilomen | Reaves Utility If | 49 | |
| Frank Fabozzi | BlackRock Health Sciences | 73 | |
| Lindsay Sinclair | BlackRock Utility Infrastructur | N/A | |
| Susan Sutherland | Eaton Vance Enhanced | 64 | |
| George Gorman | Eaton Vance Enhanced | 69 | |
BlackRock Science Tech Money Managers
| Henry Gabbay, Independent Trustee | ||
| Karen Robards, Independent Co-Chairman of the Board of Trustees | ||
| Richard Cavanagh, Independent Co-Chairman of the Board of Trustees | ||
| Charles Park, Chief Compliance Officer, Anti-Money Laundering Officer | ||
| Frank Fabozzi, Independent Trustee | ||
| J Holloman, Independent Trustee | ||
| Janey Ahn, Secretary | ||
| John Perlowski, President, Chief Executive Officer, Trustee | ||
| Michael Castellano, Independent Trustee | ||
| Cynthia Egan, Independent Trustee | ||
| Jay Fife, Treasurer | ||
| R Hubbard, Independent Trustee | ||
| Jonathan Diorio, Vice President | ||
| Robert Fairbairn, Trustee | ||
| Neal Andrews, Chief Financial Officer | ||
| Trent Walker, Chief Financial Officer | ||
| Catherine Lynch, Independent Trustee | ||
| Stayce Harris, Independent Trustee | ||
| W Kester, Independent Trustee |
BlackRock Etf Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right etf is not an easy task. Is BlackRock Science a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Shares Outstanding | 33.68 M | ||||
| Shares Owned By Insiders | 0.01 % | ||||
| Shares Owned By Institutions | 18.53 % | ||||
| Number Of Shares Shorted | 14.74 K | ||||
| Price To Earning | 5.78 X | ||||
| Short Ratio | 0.09 X | ||||
| Earnings Per Share | 5.41 X | ||||
| Number Of Employees | 17 | ||||
| Market Capitalization | 1 B | ||||
| Total Asset | 22.91 M |
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in BlackRock Etf
BlackRock Science financial ratios help investors to determine whether BlackRock Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BlackRock with respect to the benefits of owning BlackRock Science security.